Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Taiwan Stock Exchange 1762.TW

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: 5.12%

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Return on Assets (ROA) is 5.12% for the year ending December 31, 2023, a -49.82% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was 10.21%, a 11.57% change year over year.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 9.15%, a -45.87% change year over year.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 16.90%, a 396.72% change year over year.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was 3.40%, a -53.21% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Taiwan Stock Exchange: 1762.TW

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

CEO	Mr. Chung-Hsin Huang
IPO Date	Dec. 20, 2010
Location	Taiwan
Headquarters	No.1, Dongxing Street
Employees	243
Sector	Health Care
Industries Pharmaceuticals

Description

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.

Key trends

Past 5 years